Further, we assessed the performance of the 4-marker score; CD5/CD23/CD200/sIgM, in optimizing the accuracy of CLL diagnosis in resource constrained laboratories. The gene discussed is CD200; the disease is B-cell chronic lymphocytic leukemia.